HISTORY: 51 year old woman, high risk screening, recently diagnosed as BRCA1 after her sister was diagnosed with breast cancer. No personal history of breast cancer.
Summary of prior imaging
Mammography: Normal
Ultrasound: N/A
Breast MRI: N/A
FINDINGS
Quality control issues: ☐None ☐Poor/lack contrast bolus ☒Poor fat suppression
☐Susceptibility ☒Movement ☐Other
Background Parenchymal Enhancement: Minimal
Amount of Fibroglandular Tissue: Almost entirely fatty
LEFT BREAST
Narrative: Normal
BI-RADS:1: Negative
Associated findings LEFT breast: X NONE ☐Nipple retraction, ☐Nipple involvement, ☐Skin retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory, ☐Pectoral muscle invasion, ☐Chest wall invasion, ☐Architectural distortion
Non-enhancing findings LEFT breast: ☐High ductal signal pre contrast T1, ☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening, ☐Non-enhancing mass, ☐Architectural distortion, ☐Signal void from clips
Fat containing lesions LEFT: ☐Fat necrosis, ☐Hamartoma, ☐Post-operative
seroma/hematoma with fat
Lymph nodes LEFT: ☒Normal axillary, ☐Abnormal axillary, ☐ Abnormal internal mammary
RIGHT BREAST
Narrative: 2 cm area of inadequate fat suppression in the right upper inner breast which along with some movement artifact produces a false enhancement artifact (pseudolesion). No areas of enhancement of concern for malignancy.
BI-RADS:2: Benign
Associated findings RIGHT breast: XNONE ☐Nipple retraction, ☐Nipple involvement, ☐Skin retraction, ☐Skin thickening, ☐Skin invasion-direct, ☐Skin invasion-inflammatory, ☐Pectoral muscle invasion, ☐Chest wall invasion, ☐Architectural distortion
Non-enhancing findings RIGHT breast: ☐High ductal signal pre contrast T1, ☐Cyst(s), ☐Hematoma/seroma, ☐Post therapy skin/trabecular thickening, ☐Non-enhancing mass, ☐Architectural distortion, ☐Signal void from clips
Fat containing lesions RIGHT: ☐Fat necrosis, ☐Hamartoma, ☐Post-operative
seroma/hematoma with fat
Lymph nodes RIGHT: ☒Normal axillary, ☐Abnormal axillary, ☐ Abnormal internal mammary
Extramammary findings: None
SUMMARY: No evidence of malignancy
RECOMMENDATIONS: Continue annual high-risk screening.
